Skip to main content
Signal8
Field Katharyn profile photo

Katharyn Field

CIK: 0002029888

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

Advasa Holdings, Inc. logo
ADBT

Advasa Holdings, Inc.

Officer
BioRestorative Therapies, Inc. logo
BRTX

BioRestorative Therapies, Inc.

Director
LOGPROSTYLE INC. logo
LGPS

LOGPROSTYLE INC.

DirectorOfficer
Nuwellis, Inc. logo
NUWE

Nuwellis, Inc.

Director
iSpecimen Inc. logo
ISPC

iSpecimen Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • iSpecimen Inc. logo
    ISPC

    iSpecimen Inc.

    Sep 25, 2024
    Award(A)

    Option

    Direct
    168 shares at avg. $5.12-

1-1 of 1

About Field Katharyn

Field Katharyn (SEC CIK 0002029888) files insider reports with the SEC as Chief Financial Officer of Advasa Holdings, Inc. (ADBT), Director of BioRestorative Therapies, Inc. (BRTX) and Director and Executive Officer of LOGPROSTYLE INC. (LGPS). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 6 ownership filings by Field Katharyn (5 Form 3, 1 Form 4), filed between Sep 27, 2024 and Aug 11, 2026. Those filings report 1 transaction, the latest on Sep 25, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Field Katharyn's filings is in WOBURN, MA.

Recent filings by Field Katharyn

  • Sep 25, 2024: Grant or award of ISPC derivative securities (Form 4, code A).

Other insiders filing for Advasa Holdings, Inc. (ADBT)

How to read Form 4 transaction codes